VISTAGEN THERAPEUTICS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
VISTAGEN THERAPEUTICS, INC. (VTGN) had Lessee, Operating Lease, Liability, to be Paid, Year One of $754.00 thousand as of 2026-03-31, per its 10-K filed 2026-06-15.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-06-15
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $754.00K.
- 2025-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $672.00K.
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $710.00K.
- 2023-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $520.50K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-03-31 | $754.00K 10-K · filed 2026-06-15 |
| 2025-03-31 | $672.00K 10-K · filed 2025-06-17 |
| 2024-03-31 | $710.00K 10-K · filed 2024-06-11 |
| 2023-06-30 | $520.50K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $689.50K 10-K · filed 2023-06-28 |
| 2022-12-31 | $689.50K 10-Q · filed 2023-02-07 |
| 2022-09-30 | $689.50K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $689.50K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $676.00K 10-K · filed 2022-06-23 |
| 2021-12-31 | $676.00K 10-Q · filed 2022-02-10 |
| 2021-09-30 | $726.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $505.10K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $668.40K 10-K · filed 2021-06-29 |
| 2020-03-31 | $645.80K 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |